Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sante FX Neo
- Development stage
- Unknown
- Lead developer
- Santen Pharmaceutical
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
Sante FX Neo is an over-the-counter ophthalmic combination eye drop product developed and manufactured by Santen for symptomatic relief of ocular irritation and fatigue. It is a **multi-ingredient small-molecule ophthalmic solution** containing neostigmine methyl sulfate, taurine, potassium L-aspartate, tetrahydrozoline hydrochloride, chlorpheniramine maleate, and epsilon-aminocaproic acid. The formulation is intended to improve accommodative function and ocular metabolism while reducing conjunctival hyperemia, itching, and inflammation through a combination of cholinergic enhancement, metabolic support, vasoconstriction, antihistamine activity, and anti-inflammatory effects. In Japan it is marketed as a 2nd-Class OTC drug for eye fatigue, red eyes, itchy eyes, prevention of eye disease, ultraviolet-related eye inflammation, blurred vision, blepharitis, and discomfort associated with hard contact lens wear, and is known for a strong cooling sensation upon instillation.
- Brand names
- Sante FX Neo
02
Targets
AcetylcholinesteraseADRA1 (Alpha-1 adrenergic receptor family)HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on Sante FX Neo.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sante FX Neo.